Daniel W Cramer Selected Research

Tubal Sterilization (Tubal Ligation)

1/2019	Predicting Circulating CA125 Levels among Healthy Premenopausal Women.
5/2017	Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium.
11/2013	Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.
8/2013	Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin.
4/2013	Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.
2/2012	The epidemiology of endometrial and ovarian cancer.
5/2011	Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy.
6/2003	Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States).
4/2002	Does tubal sterilization influence the subsequent risk of menorrhagia or dysmenorrhea?
3/2002	The epidemiology of endometriosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel W Cramer Research Topics

Disease

96	Ovarian Neoplasms (Ovarian Cancer) 06/2022 - 02/2002
67	Neoplasms (Cancer) 06/2022 - 02/2002
35	Ovarian Epithelial Carcinoma 02/2022 - 04/2002
12	Carcinoma (Carcinomatosis) 04/2022 - 08/2007
10	Endometriosis 01/2022 - 03/2002
7	Spontaneous Abortion (Miscarriage) 01/2019 - 09/2007
6	Inflammation (Inflammations) 01/2022 - 09/2010
6	Breast Neoplasms (Breast Cancer) 01/2018 - 02/2007
6	Carcinogenesis 02/2017 - 11/2010
5	Dysmenorrhea (Menstrual Pain) 01/2021 - 03/2002
4	Infertility (Sterility) 03/2021 - 02/2002
4	Adenocarcinoma 12/2018 - 02/2006
3	Endometrial Neoplasms (Endometrial Cancer) 01/2020 - 01/2010
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022 - 05/2011
2	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 01/2022 - 11/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 06/2010
2	Ascites 03/2014 - 12/2010
2	Mastitis 11/2013 - 05/2005
2	Obesity 02/2012 - 05/2011
2	Osteoporosis 05/2005 - 06/2004
1	Fatigue 01/2021

Drug/Important Bio-Agent (IBA)

25	Biomarkers (Surrogate Marker)IBA 06/2022 - 04/2002
13	Talc FDA Link 06/2022 - 05/2005
13	AntigensIBA 11/2019 - 05/2005
12	Proteins (Proteins, Gene)FDA Link 06/2022 - 08/2003
11	Biological ProductsIBA 10/2019 - 02/2002
11	Oral ContraceptivesIBA 05/2017 - 06/2002
9	AntibodiesIBA 01/2018 - 05/2005
7	Hormones (Hormone)IBA 01/2022 - 04/2002
7	AutoantibodiesIBA 01/2018 - 10/2003
6	MicroRNAs (MicroRNA)IBA 01/2022 - 06/2011
6	ORALIT (ORS)IBA 01/2021 - 09/2010
6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 06/2002
5	Estrogens (Estrogen)FDA Link 01/2020 - 06/2002
5	Tumor Biomarkers (Tumor Markers)IBA 12/2018 - 10/2003
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2017 - 06/2009
4	SmokeIBA 01/2022 - 09/2007
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 06/2009
4	Pharmaceutical PreparationsIBA 01/2022 - 02/2002
4	Analgesics (Analgesic Drugs)IBA 01/2021 - 02/2014
4	Vitamin D FDA LinkGeneric 01/2019 - 03/2013
4	Immunoglobulin G (IgG)IBA 01/2018 - 01/2015
4	Glycoproteins (Glycoprotein)IBA 05/2017 - 01/2007
4	Lactose FDA LinkGeneric 03/2013 - 10/2002
3	Progestins (Progestagens)IBA 01/2021 - 07/2011
3	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021 - 06/2009
3	ParaffinIBA 01/2019 - 04/2002
3	Messenger RNA (mRNA)IBA 01/2018 - 04/2002
3	GonadotropinsIBA 03/2015 - 06/2004
3	Folic Acid (Vitamin M)FDA LinkGeneric 10/2014 - 11/2010
3	CarbonIBA 10/2014 - 07/2010
3	Mucin-1 (CA 15-3 Antigen)IBA 12/2010 - 05/2005
3	OsteopontinIBA 01/2006 - 04/2002
2	CA-125 Antigen (CA 125 Antigen)IBA 02/2022 - 12/2018
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 12/2015
2	PowdersIBA 01/2020 - 08/2007
2	Genetic Markers (Genetic Marker)IBA 01/2019 - 03/2002
2	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019 - 01/2014
2	N 30IBA 01/2018 - 01/2017
2	MucinsIBA 01/2018 - 11/2013
2	Insulin (Novolin)FDA Link 05/2017 - 06/2002
2	Transcription Factors (Transcription Factor)IBA 02/2017 - 01/2015
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2017 - 01/2015
2	hydroxide ionIBA 10/2016 - 01/2014
2	25-hydroxyvitamin DIBA 10/2016 - 01/2014
2	EpitopesIBA 01/2016 - 01/2010
2	ProstaglandinsIBA 12/2014 - 10/2010
2	purineIBA 10/2014 - 11/2010
2	CalciumIBA 03/2013 - 06/2004
2	Blood Group Antigens (Blood Groups)IBA 11/2012 - 01/2011
2	ABO Blood-Group SystemIBA 11/2012 - 01/2011
2	Galactose (Galactopyranose)FDA LinkGeneric 09/2012 - 10/2002
2	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2012 - 07/2010
2	MesothelinIBA 11/2011 - 02/2007
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2011 - 03/2005
2	Progesterone FDA LinkGeneric 01/2011 - 03/2005
2	Peptides (Polypeptides)IBA 07/2010 - 01/2006
2	Uridine Diphosphate (UDP)IBA 07/2010 - 02/2010
2	Caffeine (No Doz)FDA LinkGeneric 04/2009 - 03/2003
2	AndrogensIBA 07/2005 - 06/2002
1	PlatinumIBA 04/2022
1	taxaneIBA 04/2022
1	SialomucinsIBA 04/2021
1	Clomiphene (Clomifene)FDA LinkGeneric 03/2021
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2021
1	N,N-dimethyl-4-anisidine (DMPA)IBA 01/2021
1	Combined Oral ContraceptivesIBA 01/2021
1	Contraceptive Agents (Contraceptives)IBA 01/2021
1	ChromatinIBA 01/2021
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2021

Therapy/Procedure

11	Tubal Sterilization (Tubal Ligation) 01/2019 - 02/2002
7	Therapeutics 01/2022 - 06/2007
6	Hysterectomy 12/2018 - 05/2011
3	Drug Therapy (Chemotherapy) 04/2022 - 05/2004
3	Ovariectomy (Oophorectomy) 11/2013 - 05/2011
2	Neoadjuvant Therapy 04/2022 - 01/2021
2	Intrauterine Devices (Intrauterine Device) 01/2021 - 05/2005
2	Appendectomy 02/2014 - 12/2010
2	Lasers (Laser) 01/2006 - 08/2003
1	Injections 01/2021